David P Southwell - Net Worth and Insider Trading

David P Southwell Net Worth

The estimated net worth of David P Southwell is at least $4 Million dollars as of 2024-04-26. David P Southwell is the Director of Rocket Pharmaceuticals Inc and owns about 114,784 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $3 Million. David P Southwell is the CEO of TScan Therapeutics Inc and owns about 171,569 shares of TScan Therapeutics Inc (TCRX) stock worth over $1 Million. David P Southwell is also the Director of PTC Therapeutics Inc and owns about 10,500 shares of PTC Therapeutics Inc (PTCT) stock worth over $267,645. Besides these, David P Southwell also holds First Eagle Alternative Capital BDC Inc (FCRD) . Details can be seen in David P Southwell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David P Southwell has not made any transactions after 2024-04-15 and currently still holds the listed stock(s).

Transaction Summary of David P Southwell

To

David P Southwell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David P Southwell owns 5 companies in total, including PTC Therapeutics Inc (PTCT) , Rocket Pharmaceuticals Inc (RCKT) , and Spero Therapeutics Inc (SPRO) among others .

Click here to see the complete history of David P Southwell’s form 4 insider trades.

Insider Ownership Summary of David P Southwell

Ticker Comapny Transaction Date Type of Owner
PTCT PTC Therapeutics Inc 2023-04-17 director
RCKT Rocket Pharmaceuticals Inc 2018-12-13 director & See Remarks
SPRO Spero Therapeutics Inc 2018-02-01 director
FCRD First Eagle Alternative Capital BDC Inc 2010-12-06 director
TCRX TScan Therapeutics Inc 2022-05-18 director & Chief Executive Officer

David P Southwell Latest Holdings Summary

David P Southwell currently owns a total of 4 stocks. Among these stocks, David P Southwell owns 114,784 shares of Rocket Pharmaceuticals Inc (RCKT) as of April 15, 2024, with a value of $3 Million and a weighting of 59.97%. David P Southwell owns 171,569 shares of TScan Therapeutics Inc (TCRX) as of May 18, 2022, with a value of $1 Million and a weighting of 29.57%. David P Southwell also owns 10,500 shares of PTC Therapeutics Inc (PTCT) as of April 17, 2023, with a value of $267,645 and a weighting of 6.33%. The other 1 stocks First Eagle Alternative Capital BDC Inc (FCRD) have a combined weighting of 4.13% among all his current holdings.

Latest Holdings of David P Southwell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RCKT Rocket Pharmaceuticals Inc 2024-04-15 114,784 22.10 2,536,726
TCRX TScan Therapeutics Inc 2022-05-18 171,569 7.29 1,250,738
PTCT PTC Therapeutics Inc 2023-04-17 10,500 25.49 267,645
FCRD First Eagle Alternative Capital BDC Inc 2010-12-06 38,500 4.54 174,790

Holding Weightings of David P Southwell


David P Southwell Form 4 Trading Tracker

According to the SEC Form 4 filings, David P Southwell has made a total of 1 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Rocket Pharmaceuticals Inc is the sale of 80,000 shares on April 15, 2024, which brought David P Southwell around $2 Million.

According to the SEC Form 4 filings, David P Southwell has made a total of 2 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 25,000 shares on May 18, 2022, which cost David P Southwell around $89,750.

According to the SEC Form 4 filings, David P Southwell has made a total of 3 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 11,429 shares on April 17, 2023, which brought David P Southwell around $583,222.

More details on David P Southwell's insider transactions can be found in the Insider Trading History of David P Southwell table.

Insider Trading History of David P Southwell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David P Southwell Trading Performance

GuruFocus tracks the stock performance after each of David P Southwell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Southwell is -2.03%. GuruFocus also compares David P Southwell's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Southwell within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David P Southwell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David P Southwell

Average Return

-3.92%

Average return per transaction

Outperforming Transactions

13%

1 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.87 -2.03 -12.79 -3.92 3.99 15.21
Relative Return to S&P 500(%) -4.1 -10.81 -19.18 -6.29 -2.43 0.94

David P Southwell Ownership Network

Ownership Network List of David P Southwell

No Data

Ownership Network Relation of David P Southwell


David P Southwell Owned Company Details

What does PTC Therapeutics Inc do?

Who are the key executives at PTC Therapeutics Inc?

David P Southwell is the director of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include Chief Development Officer Matthew B. Klein , Chief Business Officer Eric Pauwels , and Chief Medical Officer Lee Scott Golden .

PTC Therapeutics Inc (PTCT) Insider Trades Summary

Over the past 18 months, David P Southwell made 2 insider transaction in PTC Therapeutics Inc (PTCT) with a net sale of 21,429. Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 25,597 shares made by Eric Pauwels , a net sale of 41,134 shares made by Christine Marie Utter , and a net sale of 28,914 shares made by Matthew B. Klein .

In summary, during the past 3 months, insiders sold 8,105 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 8,105 shares. During the past 18 months, 273,917 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 266,217 shares.

PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PTC Therapeutics Inc Insider Transactions

No Available Data

David P Southwell Mailing Address

Above is the net worth, insider trading, and ownership report for David P Southwell. You might contact David P Southwell via mailing address: C/o Inotek Pharmaceuticals Corporation, 91 Hartwell Avenue, Lexington Ma 02421.

Discussions on David P Southwell

No discussions yet.